Comparison of the Acute Antihypertensive Response to Telmisartan and Irbesartan in Spontaneously Hypertensive Rats

pp. 8-13

Abstract

Background: Telmisartan and irbesartan, two of the main AT1 receptor antagonists available for the control of cardiovascular diseases, differ in their pharmacological properties, including time of dissociation from the AT1 receptor and the ability to activate other receptors, with potential impact on their relative clinical efficacy.
Objectives: The aim of this study was to compare the acute cardiovascular response to single dose administration of irbesartan or telmisartan in spontaneously hypertensive rats.
Methods: Twenty-four male spontaneously hypertensive rats, weighing 250-275 g, were used. The carotid artery and femoral vein were cannulated for direct mean arterial pressure measurement (MAP) and irbesartan 3-6 mg/kg or telmisartan 0,5-1 mg/kg administration. Changes in MAP, heart rate and short-term and beat-to-beat blood pressure variability were estimated.
Results: Although both antagonists reduced MAP, telmisartan induced a longer antihypertensive response than irbesartan, evidenced by greater MAP reduction after 180 min (-33.3%±4.1% vs. -16.3%±4%; p<0.05). Telmisartan and irbesartan induced sustained reduction of short-term blood pressure variability without significant differences between both experimental groups. At the lower dose level, telmisartan produced greater decrease of heart rate and beat-to-beat blood pressure variability at the different frequency domains compared with irbesartan.
Conclusions: In spontaneously hypertensive rats, telmisartan administration induces a more persistent antihypertensive response and a greater bradycardic response than irbesartan. Spectral analysis of beat-to-beat blood pressure variability suggests that low dose telmisartan produces greater attenuation of vascular sympathetic activity compared with irbesartan.